Acromegaly Pipeline, Clinical Trials Assessment, FDA Approvals, and Emerging Drugs 2023 (Updated)

 Breaking News
  • No posts were found

Acromegaly Pipeline, Clinical Trials Assessment, FDA Approvals, and Emerging Drugs 2023 (Updated)

November 10
20:25 2023
Acromegaly Pipeline, Clinical Trials Assessment, FDA Approvals, and Emerging Drugs 2023 (Updated)

DelveInsight’s ‘Acromegaly Pipeline Insight 2023‘ report provides comprehensive global coverage of available, marketed, and Acromegaly Pipeline therapies in various stages of Acromegaly clinical trials development, major pharmaceutical Acromegaly Companies are working to advance the Acromegaly pipeline space and future growth potential of the Acromegaly pipeline domain. 

 

For Acromegaly emerging drugs, the Acromegaly pipeline analysis report provides a 360° view of the therapeutics landscape by development point, product type, route of administration, molecule type, and MOA. The Acromegaly pipeline research covers business opportunities, challenges, future partnerships, strong competitors, and growth strategies. 

 

Key takeaways from the Acromegaly Pipeline Insight Report 

  • Over 15+ Acromegaly companies are evaluating 15+ Acromegaly pipeline therapies in various stages of development, and their anticipated acceptance in the Acromegaly market would significantly increase market revenue. 
  • The leading Acromegaly Companies includes Ionis Pharmaceuticals, Crinetics Pharmaceuticals, Camurus, Ono Pharmaceutical, Aquestive Therapeutics, Strongbridge Biopharma, Italfarmaco, Ipsen, Antisense Therapeutics, Dauntless Pharmaceuticals, TTY Biopharm, Peptron, DexTech Medical AB, Rani Therapeutics, OPKO Health, Inc., Amolyt Pharma, Foresee Pharmaceuticals, ADVANZ PHARMA, and others. 
  • Promising Acromegaly Pipeline Therapies includes octreotide FluidCrystal® injection depot, IONIS-GHR-LRx, SRL, Paltusotine, CAM2029 (octreotide subcutaneous depot), and others. 
  • The Acromegaly companies and academics are working to assess challenges and seek opportunities that could influence Acromegaly R&D. The Acromegaly pipeline therapies under development are focused on novel approaches to treat/improve Acromegaly.

 

Request a sample and discover the recent breakthroughs happening in the Acromegaly pipeline landscape @ Acromegaly Pipeline Outlook Report

 

Acromegaly Overview

Acromegaly is a disorder that occurs when your body makes too much growth hormone (GH). Produced mainly in the pituitary gland, GH controls the physical growth of the body. In adults, too much of this hormone causes bones, cartilage, body organs, and other tissues to increase in size. Common changes in appearance include enlarged or swollen nose, ears, hands, and feet.

 

 Acromegaly Emerging Drugs Profile

  • IONIS-GHR-LRX: Ionis Pharmaceuticals
  • Paltusotine: Crinetics Pharmaceuticals

 

Find out more about the Acromegaly Diagnosis and Treatment of patients @ Acromegaly Ongoing Clinical Trials Analysis

 

Acromegaly Key Companies and Pipeline Therapies

  • octreotide FluidCrystal® injection depot: Ionis Pharmaceuticals
  • IONIS-GHR-LRx: Crinetics Pharmaceuticals
  • SRL: Camurus
  • Paltusotine: Ono Pharmaceutical
  • CAM2029 (octreotide subcutaneous depot): Aquestive Therapeutics

 

Acromegaly Pipeline Therapeutics Assessment

Phases

  • Late stage products (Phase III)
  • Mid-stage products (Phase II)
  • Early-stage product (Phase I) along with the details of
  • Pre-clinical and Discovery stage candidates
  • Discontinued & Inactive candidates
  • Route of Administration

 

Route of Administration

  • Oral
  • Parenteral
  • Intravenous
  • Subcutaneous
  • Topical

 

Molecule Type

  • Monoclonal Antibody
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy
  • Product Type

 

Discover more about the list of Acromegaly FDA-approved drugs for Acromegaly @ Acromegaly Treatment Landscape

 

Scope of the Acromegaly Pipeline Report

  • Coverage- Global
  • Acromegaly Companies- Ionis Pharmaceuticals (NYSE: IONS), Crinetics Pharmaceuticals (NYSE: CRNX), Camurus (NYSE: CAMX), Ono Pharmaceutical (NYSE: OPHLF), Aquestive Therapeutics (NYSE: AQST), Strongbridge Biopharma (NYSE: SBBP), Italfarmaco, Ipsen, Antisense Therapeutics (NYSE: ATHJF), Dauntless Pharmaceuticals, TTY Biopharm, Peptron, DexTech Medical AB (NYSE: DEX), Rani Therapeutics (NYSE: RANI), OPKO Health Inc (NYSE: OPK)., Amolyt Pharma, Foresee Pharmaceuticals, ADVANZ PHARMA, and others.
  • Acromegaly Pipeline Therapies- octreotide FluidCrystal® injection depot, IONIS-GHR-LRx, SRL, Paltusotine, CAM2029 (octreotide subcutaneous depot), and others
  • Acromegaly Pipeline Segmentation: Phases, Mechanism of Action, Route of Administration, Product Type

 

Dive deep into rich insights for Acromegaly Emerging Therapies and Ongoing Clinical Trials; visit @ Acromegaly Emerging Therapies and Key Players

 

Table of Content

  1. Introduction
  2. Executive Summary
  3. Acromegaly: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Late Stage Products (Phase III)
  7. Paltusotine: Crinetics Pharmaceuticals
  8. Drug profiles in the detailed report…..
  9. Mid Stage Products (Phase II)
  10. IONIS-GHR-LRX: Ionis Pharmaceuticals
  11. Drug profiles in the detailed report…..
  12. Early Stage Products (Phase I)
  13. RaniPill: Rani Therapeutics
  14. Drug profiles in the detailed report…..
  15. Preclinical and Discovery Stage Products
  16. AZP-3800: Amolyt Pharma
  17. Drug profiles in the detailed report…..
  18. Inactive Products
  19. Acromegaly Key Companies
  20. Acromegaly Key Products
  21. Acromegaly- Unmet Needs
  22. Acromegaly- Market Drivers and Barriers
  23. Acromegaly- Future Perspectives and Conclusion
  24. Acromegaly Analyst Views
  25. Acromegaly Key Companies
  26. Appendix

 

For further information on the Acromegaly Pipeline therapeutics, reach out to Acromegaly Market Drivers and Barriers

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/consulting-services

Related Articles

Categories